# Adalimumab-adbm

NDC: 82009-148
Generic name: Adalimumab-adbm
Labeler / Manufacturer: QUALLENT PHARMACEUTICALS HEALTH LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20240430

FDA application: BLA761058

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82009-148"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82009-148
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f9986706-9c75-4335-a54f-09d7716dbcef